OpenLB
Open Library of Bioscience
Advanced Search
The Journal of antibiotics
Mar, 2016;69 (3): 173-5.

Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates.

Guilian Li, Jingrui Zhang, Chao Li, Qian Guo, Yi Jiang, Jianhao Wei, Yan Qiu, Xiuqin Zhao, Li-li Zhao, Jianxin Lu, Kanglin Wan
Author Information
  1. Guilian Li: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  2. Jingrui Zhang: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  3. Chao Li: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  4. Qian Guo: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  5. Yi Jiang: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  6. Jianhao Wei: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  7. Yan Qiu: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  8. Xiuqin Zhao: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  9. Li-li Zhao: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  10. Jianxin Lu: Key Laboratory of Laboratory Medicine, Wenzhou Medical College, Wenzhou, China.
  11. Kanglin Wan: State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
PMID: 26464012 DOI: 10.1038/ja.2015.101

Abstract

No abstract text available.

References

  1. Am J Respir Crit Care Med. 2011 Jul 15;184(2):269-76 [PMID: 21512166]
  2. FEMS Microbiol Lett. 2009 Feb;291(1):35-43 [PMID: 19054072]
  3. PLoS One. 2015 Apr 24;10(4):e0123883 [PMID: 25910232]
  4. Indian J Med Res. 2010 Aug;132:176-88 [PMID: 20716818]
  5. Trop Med Int Health. 2001 Dec;6(12):1016-22 [PMID: 11737839]
  6. Mol Microbiol. 1999 Jan;31(1):394-5 [PMID: 9987140]
  7. J Clin Microbiol. 2010 May;48(5):1853-8 [PMID: 20237102]
  8. Antimicrob Agents Chemother. 2005 Nov;49(11):4775-7 [PMID: 16251328]
  9. PLoS One. 2012;7(4):e34538 [PMID: 22493700]
  10. J Clin Microbiol. 1997 Apr;35(4):907-14 [PMID: 9157152]
  11. J Clin Microbiol. 2008 Oct;46(10):3526-9 [PMID: 18701659]
  12. Antimicrob Agents Chemother. 2010 Dec;54(12):5167-72 [PMID: 20921309]
  13. Microb Drug Resist. 2010 Mar;16(1):21-8 [PMID: 20001742]
  14. Antimicrob Agents Chemother. 2002 Sep;46(9):2804-10 [PMID: 12183232]
  15. FEMS Microbiol Rev. 2006 Jan;30(1):36-52 [PMID: 16438679]
  16. Infect Genet Evol. 2012 Jun;12(4):695-700 [PMID: 21871582]
  17. PLoS One. 2013 Dec 30;8(12):e84065 [PMID: 24386332]

MeSH Term

Adult
Antitubercular Agents
Carbonyl Cyanide m-Chlorophenyl Hydrazone
China
Chlorpromazine
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Reserpine
Thioridazine
Tuberculosis, Pulmonary
Verapamil

Chemicals

Antitubercular Agents
Carbonyl Cyanide m-Chlorophenyl Hydrazone
Reserpine
Verapamil
Thioridazine
Chlorpromazine
Journal Article Research Support, Non-U.S. Gov't
Article has an altmetric score of 7

Word Cloud

Created with Highcharts 10.0.0AntimycobacterialactivityfiveeffluxpumpinhibitorsMycobacteriumtuberculosisclinicalisolates

Similar Articles

Cited By